Results 161 to 170 of about 14,984 (246)

The Ethnopharmacological Use of Mescaline for Psychiatric Disorders: A Systematic Review. [PDF]

Int J Mol Sci
Shaw J, Yong A, Lee J, Cheng J, Andricioaei A, Wang JY, Zisman-Ilani Y, Bota R.   +7 more
europepmc   +1 more source

Toward a framework for psychedelic clinical trials in adolescents. [PDF]

Child Adolesc Psychiatry Ment Health
Moore CK, Riordan HJ, Avrumson R, Auby P.   +3 more
europepmc   +1 more source

Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model. [PDF]

ACS Chem Neurosci
Kandilakis CL, Papatheodoropoulos C.
europepmc   +1 more source

Excusing Psychedelics and Accommodating Psychedelics

The American Journal of Bioethics
openaire   +2 more sources

Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility. [PDF]

Front Neurosci
Evans M, Charrette A.
europepmc   +1 more source

Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century. [PDF]

BJPsych Open
Bender DA, Dunn HM, Pekau A, Mohite AD, Anandarajah A, Ross BD, Steinle J, Shankar S, Kiley B, Martin S, Gonuguntla R, Stonov M, Pippala N, Abdalla R, Stille MK, Yusuf J, Villalba M, Werner G, Divekar A, Daniels-Tineo M, Wang H, Chertock S, Sharma S, Ahmed SA, Bandyopadhyay R, Sridhar J, Iyer M, Adeyemi A, Smart K, Jalil U, Alam Z, Ercal BC, Hellerstein DJ, Nemeroff CB.   +33 more
europepmc   +1 more source

An international mega-analysis of psychedelic drug effects on brain circuit function. [PDF]

Nat Med
Girn M, Doss MK, Roseman L, Preller KH, Palhano-Fontes F, Pasquini L, Barrett FS, Mallaroni P, Mason NL, Timmermann C, McCulloch DE, Fisher PM, Winston BS, Moujaes F, Muller F, Liechti ME, Vollenweider FX, Ramaekers JG, Kuypers K, Araujo DB, Sporns O, Siegel J, Dosenbach N, Nutt DJ, Carhart-Harris RL, Stamatakis EA, Bzdok D.   +26 more
europepmc   +1 more source

Editorial: Psychedelic humanities

Frontiers in Psychology
Tehseen Noorani, Oliver Davis, Alex Dymock, Nicolas Langlitz, Anne K. Schlag, Erika Dyck   +5 more
openaire   +3 more sources

Editorial: Psychedelic substances and neurological diseases: from basics to clinical application. [PDF]

Front Pharmacol
Linardi A, Caetano AL, Ureshino RP.
europepmc   +1 more source

Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology. [PDF]

Front Pharmacol
Geraci J, Viirre E, Qorri B, Pani L.
europepmc   +1 more source